J.S. Remick
Papers
1
Total Citations
1
H-Index
1
About
J.S. Remick is a clinical researcher whose work focuses on optimizing treatment strategies for head and neck cancers, particularly oropharyngeal squamous cell carcinoma. Their key research areas include therapeutic decision-making, prognostic factors, and the integration of multimodal care in oncology. Remick’s most notable contribution, the 2022 study "Factors Predictive of Primary Therapeutic Modality in Early-Stage Oropharyngeal Squamous Cell Carcinoma," identifies critical clinical and pathological variables—such as tumor staging, HPV status, and patient comorbidities—that guide the choice between surgery, radiation, or chemoradiation. This work provides a framework for personalized treatment, aiming to improve outcomes while minimizing toxicity. Though the paper has garnered 1 citation to date, its relevance lies in addressing a pressing clinical dilemma: how to tailor therapy in an era of de-escalation protocols. Remick’s research underscores the importance of evidence-based, patient-centered care, offering valuable insights for oncologists and trainees navigating complex treatment landscapes. Their contributions highlight a commitment to advancing precision oncology in head and neck malignancies.
Research Focus
Key Achievements
Top Papers
- 1